Navigation Links
AMICAS Announces Integrations at More Than 100 MEDITECH Facilities
Date:5/27/2008

Vision Series PACS milestone is a testament to tight integration and

excellent value

BOSTON, May 27 /PRNewswire-FirstCall/ -- AMICAS, Inc. (Nasdaq: AMCS), a leader in radiology and medical image and information management solutions, today announced that it has successfully integrated its Vision Series(TM) PACS at more than 100 facilities that use MEDITECH(TM) as their health information system. AMICAS will be showcasing Vision Series PACS at the 2008 International Medical Users Software Exchange (MUSE) Conference in Dallas, TX, from May 27 to 30. AMICAS will be in booth #530.

(Logo: http://www.newscom.com/cgi-bin/prnh/20060202/AMICASLOGO )

"AMICAS has a proven track record of successfully implementing our PACS at more than 100 MEDITECH facilities across the country," said Paul Merrild, vice president of marketing at AMICAS. "Many facilities throughout the country have made an investment in MEDITECH -- and AMICAS allows them to fully leverage their investment when they choose our Vision Series PACS."

AMICAS is focused on developing solutions that allow facilities running a MEDITECH health information system to realize superior integration and value from their investment with MEDITECH. Complementing MEDITECH's core applications, the AMICAS product suite includes the following functionality:

-- Vision Series PACS offers the capability to securely launch an

encrypted image viewer that is embedded within numerous MEDITECH

products, including PCI and EMR. This allows users in other MEDITECH

applications to be "image-aware" without disrupting their daily

workflow, seamlessly launching the AMICAS products on an as-needed

basis.

-- Vision Watch(TM) offers reporting functionality that complements the

tools found in the MEDITECH RIS. These capabilities empower radiology

administrators with easily accessible information required to run their

departments and facilities effectively, such as data on referring

physician volume reports, imaging equipment utilization, and HIPAA

reporting needs -- all in a Web-based, drill-down, "point and click"

user interface.

-- Vision Series PACS includes a bi-directional interface with all

MEDITECH platforms. This interface returns relevant clinical data to

radiologists at their PACS workstations in order to enhance their

ability to diagnose their patients, thus increasing their efficiency

and that of the entire radiology department or facility.

"AMICAS' dedication to making MEDITECH customers successful extends beyond technical capabilities. We have invested, and will continue to invest, in products and services that complement those provided by MEDITECH. We focus on being collaborative and cooperative with MEDITECH for the benefit of our mutual customers. We believe this focus differentiates us from other PACS companies in the market," said Mr. Merrild.

AMICAS, Vision Series, and Vision Watch are trademarks or registered trademarks of AMICAS, Inc. All other company and trademark names are the property of their respective owners.

About AMICAS, Inc.

AMICAS, Inc. (http://www.amicas.com) is a leader in radiology and medical image and information management solutions. The AMICAS(R) Vision Series(TM) products provide a complete, end-to-end solution for imaging centers, ambulatory care facilities, and radiology practices. Acute care and hospital clients are provided a fully-integrated, HIS/RIS-independent PACS, featuring advanced enterprise workflow support and scalable design. Complementing the Vision Series product family is AMICAS Insight(TM) Solutions, a set of client- centered professional and consulting services that assist our customers with a well-planned transition to a digital enterprise.

CONTACT:

Aine Cryts

Marketing Communications Manager

617.779.7878

acryts@amicas.com


'/>"/>
SOURCE AMICAS, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. AMICAS Reports Financial Results for the First Quarter Ended March 31, 2008
2. AMICAS to Present at CIBC World Markets 18th Annual Healthcare Conference
3. CV Therapeutics Announces Presentations at the American Diabetes Association 68th Scientific Sessions
4. Epitomics Announces the Creation of 1000th Rabbit Monoclonal Antibody
5. NicOx Announces Departure of Damian Marron for CEO Position
6. CellCyte Genetics Corporation Announces Launch of Comprehensive Web site Powered by PRNewswire Investor Room Backend Technology
7. Favrille Announces Results from Phase 3 Registration Trial of Specifid in Patients with Follicular B-Cell Non-Hodgkins Lymphoma
8. Dragon Pharma Announces June 26, 2008 for 2008 Annual Shareholders Meeting
9. Cardium Therapeutics Announces Annual Meeting of Stockholders to be Held June 5, 2008
10. Oncolytics Biotech Inc. Announces Issuance of 9th Canadian Patent
11. Amnis Announces Release of Its Extended Depth of Field Option for The ImageStream(R) System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... January 24, 2017 , ... ... PRM, a chronic disease and transitions of care solution for use by healthcare ... to work at the top of their license. Care teams, care managers ...
(Date:1/24/2017)... DURHAM, N.C. , Jan. 24, 2017 ... service and technology, announces that Daniel Eisenman , ... Biosafety Officer. In his new role, ... and manage a forthcoming institutional biosafety committee (IBC) service. ... navigating the IBC landscape. The new IBC service represents ...
(Date:1/24/2017)... 2017 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ) ... to increase the size of the offering by 75% and ... with warrants to purchase 1,842,106 shares of common stock of ... of common stock (the "Exercise Price"), at a price to ... "Public Price"). The warrants have a term of four (4) ...
(Date:1/24/2017)... USA & Geneva, Switerland (PRWEB) , ... January ... ... to announce the first commercially available malaria Plasmodium falciparum culture panels with standard ... falciparum culture panels, which are available in a range of concentrations from six ...
Breaking Biology Technology:
(Date:12/20/2016)... and GENEVA, Dec, 20, 2016   Valencell , ... technology, and STMicroelectronics (NYSE: STM), a global ... electronics applications, announced today the launch of a ... biometric wearables that includes ST,s compact SensorTile ... Benchmark™ biometric sensor system. Together, SensorTile and ...
(Date:12/16/2016)... , Dec 16, 2016 Research and ... System Market - Global Forecast to 2021" report to their ... The ... to grow at a CAGR of 14.06% from 2016 to 2021. ... and is projected to reach 854.8 Million by 2021. The growth ...
(Date:12/15/2016)... Calif. , Dec. 15, 2016   WaferGen ... publicly held genomics technology company, announced today that on ... Listing Qualifications Department of The Nasdaq Stock Market LLC ... closing bid price of WaferGen,s common stock had been ... Accordingly, WaferGen has regained compliance with Listing Rule 5550(a)(2) ...
Breaking Biology News(10 mins):